Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN109651424B reveals a cost-effective synthesis route for key pharmaceutical intermediates, offering significant supply chain advantages for global API manufacturers.
Patent CN100564357C reveals a palladium-free route for azetidinone derivatives. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN1473832A details a novel catalytic synthesis for d-biotin intermediates, offering superior yield and purity for reliable pharmaceutical supply chains.
Patent CN105017158B reveals a novel synthesis route for cis-Rosuvastatin calcium impurities, offering high purity and scalable production for global supply chains.
Patent CN106749445A reveals a stable, high-yield synthesis for epirubicin intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN120795037B details novel ruthenium compounds with superior antibacterial activity. Discover cost-effective synthesis and reliable supply chain solutions for pharmaceutical intermediates.
Novel nitro-reduction route avoids column chromatography, ensuring high purity and yield for scalable API manufacturing.
Patent CN104093718B reveals a solvent-free Cu-catalyzed process enabling high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability.
Patent CN107216326A reveals novel tandem catalysis for phenanthridine derivatives. Enables cost reduction and scalable supply for high-purity pharmaceutical intermediates manufacturing.
Novel thiourea-catalyzed asymmetric synthesis of trifluoromethyl bisoxazoles with high ee. Ideal for anticancer drug development and cost-effective API manufacturing.
Novel Ru/Ni dual-catalyzed method for cyano-enamines offers mild conditions and high selectivity, optimizing pharmaceutical intermediate supply chains.
Patent CN113735926A reveals a high-yield diazotization route for uridine production, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN112321535B reveals a novel ketone-based route for Imaric Acid, offering high purity and cost reduction for Imatinib manufacturing supply chains.
Novel four-step synthesis of PARP1 inhibitor intermediate via nitration and oxidative deamination. Offers high purity and scalable route for pharmaceutical manufacturing.
Patent CN113185419B reveals a greener 4-step route for oxybuprocaine hydrochloride, eliminating genotoxic risks and enabling cost-effective commercial scale-up.
Patent CN114853797B reveals a mild selenium-catalyzed method for alpha-amino boron compounds, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel Cs2CO3 catalyzed route offers high yield dihydrofuran intermediates. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical partners.
Patent CN104591938A reveals high-yield Pd-catalyzed route. Offers supply chain stability and cost efficiency for global pharmaceutical intermediate manufacturing partners.
Novel patent CN107629014A offers mild conditions for triazole intermediate production ensuring supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Patent CN101891794B details a novel ursolic acid piperazine derivative with superior antitumor activity. Discover scalable synthesis routes and cost-effective manufacturing strategies.